Mr. Jeffrey R Lindstrom, an executive Director and the President of our Company. He is mainly responsible for participating in the total management and strategic development of our Group.
Mr. Lindstrom has over 25 years R&D experience in the minimally invasive interventional medical device industry. He joined the Group as Vice President (R&D) from January 1, 2022 to August 29, 2023. Prior to joining the Group, he served as senior director of engineering in Edwards Lifesciences Corporation (New York Stock Exchange ticker symbol: EW) since 2012, where he was responsible for developing the R&D strategy, directing and managing the R&D activities, overseeing the full product development lifecycle, leading the development and commercialization of the electro-mechanical transcatheter heart valve system and leading the development and clinical evaluation of the embolic protection system. From 2008 to 2012, he served as R&D director of The Spectranetics Corporation. From 1998 to 2006, he served as R&D manager of Abbott Vascular (formerly known as Guidant Corporation).
Mr. Lindstrom obtained his bachelor’s degree in chemical engineering from Illinois Institute of Technology in the United States in 1996. He also obtained the certificate of general management from UCLA Anderson School of Management in the United States in 2016. He owns six patents relating to the cardiovascular medical devices.
